Literature DB >> 17377101

Left ventricular performance and dimensions in patients with severe emphysema.

Kirsten Jörgensen1, Erik Houltz, Ulla Westfelt, Sven-Erik Ricksten.   

Abstract

BACKGROUND: Concomitant heart dysfunction during the course of chronic obstructive pulmonary disease is well recognized. The prevailing view is that mainly the right side of the heart is involved. We evaluated left ventricular (LV) function and dimensions in patients with severe emphysema.
METHODS: Patients with severe emphysema undergoing lung volume reduction surgery were studied after anesthesia induction (n = 10). Non-emphysematous patients scheduled for lobectomy served as controls (n = 10). LV dimensions were measured with patients in the supine position by transesophageal two-dimensional echocardiography and systemic hemodynamics by a pulmonary artery thermodilution catheter, before and during central blood volume expansion by passive leg elevation.
RESULTS: Baseline cardiac index (-25%), stroke volume index (SVI, -32%) stroke work index (-34%) and LV end-diastolic area index (EDAI, -33%) were significantly (P < 0.001) lower in the emphysema group. Passive leg elevation increased SVI and LV area ejection fraction more in the emphysema group than in controls (P < 0.05). The DeltaSVI/Delta pulmonary capillary wedge pressure and the DeltaSVI/DeltaEDAI relationships were significantly (P < 0.05) higher in the emphysema group compared to controls (2.2 +/- 0.71 vs 0.6 +/- 0.2 mL/mm Hg x m2 and 5.8 +/- 0.89 vs 2.8 +/- 0.8 mL/cm2 x m2, respectively). Preload-recruitable stroke work (Deltastroke work index/DeltaEDAI), a load-independent index of systolic LV function, did not differ between the two groups.
CONCLUSION: The LV in patients with severe emphysema is hypovolemic, and operates on a steeper portion of the LV function curve, while indices of systolic function are not significantly impaired compared to non-emphysematous controls.

Entities:  

Mesh:

Year:  2007        PMID: 17377101     DOI: 10.1213/01.ane.0000258020.27849.6b

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  Smaller Left Ventricle Size at Noncontrast CT Is Associated with Lower Mortality in COPDGene Participants.

Authors:  George R Washko; Pietro Nardelli; Samuel Y Ash; Farbod N Rahaghi; Gonzalo Vegas Sanchez-Ferrero; Carolyn E Come; Mark T Dransfield; Ravi Kalhan; MeiLan K Han; Surya P Bhatt; J Michael Wells; Carrie L Pistenmaa; Alejandro A Diaz; James C Ross; Stephen Rennard; Gabriela Querejeta Roca; Amil M Shah; Kendra Young; Gregory L Kinney; John E Hokanson; Alvar Agustí; Raúl San José Estépar
Journal:  Radiology       Date:  2020-05-05       Impact factor: 11.105

2.  Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study.

Authors:  George R Washko; Pietro Nardelli; Samuel Y Ash; Gonzalo Vegas Sanchez-Ferrero; Farbod N Rahaghi; Carolyn E Come; Mark T Dransfield; Ravi Kalhan; MeiLan K Han; Surya P Bhatt; J Michael Wells; Carrie Pistenmaa Aaron; Alejandro A Diaz; James C Ross; Michael J Cuttica; Wassim W Labaki; Gabriela Querejeta Roca; Amil M Shah; Kendra Young; Gregory L Kinney; John E Hokanson; Alvar Agustí; Raúl San José Estépar
Journal:  Am J Respir Crit Care Med       Date:  2019-08-15       Impact factor: 21.405

3.  Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study.

Authors:  Benjamin M Smith; Martin R Prince; Eric A Hoffman; David A Bluemke; Chia-Ying Liu; Dan Rabinowitz; Katja Hueper; Megha A Parikh; Antoinette S Gomes; Erin D Michos; João A C Lima; R Graham Barr
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

4.  Influence of cigarette smoking on biventricular systolic function independent of respiratory function: a cross-sectional study.

Authors:  Yusuke Watanabe; Kazuko Tajiri; Atsuko Suzuki; Hiroyuki Nagata; Masayuki Kojima
Journal:  BMC Cardiovasc Disord       Date:  2020-10-15       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.